G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision Medicine.

Valentine SuteauValérie SeegersMathilde MunierRym Ben BoubakerCécile ReyesDavid GentienMéline WeryAnne CrouéFrédéric IllouzAntoine HamyPatrice RodienClaire Briet

Published in: The Journal of clinical endocrinology and metabolism (2021)

For the first time, we performed GPCR mRNA expression profiling in progressive and refractory thyroid cancers. These findings provide an opportunity to identify potential therapeutic targets for drug repositioning and precision medicine in radioiodine-refractory thyroid cancer.

Keyphrases

multiple sclerosis
gene expression
human health